QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Checkpoint Therapeutics (CKPT) Competitors

$2.32
+0.09 (+4.04%)
(As of 03/4/2024 ET)

CKPT vs. AADI, BYSI, FIXX, BIVI, ELDN, IPA, NXTC, LTRN, BOLT, and MIST

Should you be buying Checkpoint Therapeutics stock or one of its competitors? The main competitors of Checkpoint Therapeutics include Aadi Bioscience (AADI), BeyondSpring (BYSI), Homology Medicines (FIXX), BioVie (BIVI), Eledon Pharmaceuticals (ELDN), ImmunoPrecise Antibodies (IPA), NextCure (NXTC), Lantern Pharma (LTRN), Bolt Biotherapeutics (BOLT), and Milestone Pharmaceuticals (MIST). These companies are all part of the "pharmaceutical preparations" industry.

Checkpoint Therapeutics vs.

Checkpoint Therapeutics (NASDAQ:CKPT) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, valuation, profitability and risk.

Checkpoint Therapeutics has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Aadi Bioscience has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Checkpoint Therapeutics received 158 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 66.02% of users gave Checkpoint Therapeutics an outperform vote while only 50.00% of users gave Aadi Bioscience an outperform vote.

CompanyUnderperformOutperform
Checkpoint TherapeuticsOutperform Votes
169
66.02%
Underperform Votes
87
33.98%
Aadi BioscienceOutperform Votes
11
50.00%
Underperform Votes
11
50.00%

In the previous week, Aadi Bioscience had 3 more articles in the media than Checkpoint Therapeutics. MarketBeat recorded 9 mentions for Aadi Bioscience and 6 mentions for Checkpoint Therapeutics. Checkpoint Therapeutics' average media sentiment score of 0.70 beat Aadi Bioscience's score of 0.65 indicating that Checkpoint Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Checkpoint Therapeutics
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aadi Bioscience
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

14.8% of Checkpoint Therapeutics shares are owned by institutional investors. Comparatively, 58.3% of Aadi Bioscience shares are owned by institutional investors. 4.4% of Checkpoint Therapeutics shares are owned by company insiders. Comparatively, 35.8% of Aadi Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Checkpoint Therapeutics currently has a consensus target price of $22.60, indicating a potential upside of 874.14%. Aadi Bioscience has a consensus target price of $24.67, indicating a potential upside of 913.00%. Given Aadi Bioscience's higher possible upside, analysts plainly believe Aadi Bioscience is more favorable than Checkpoint Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Checkpoint Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aadi Bioscience
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Aadi Bioscience has higher revenue and earnings than Checkpoint Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Checkpoint Therapeutics$190K287.31-$62.62MN/AN/A
Aadi Bioscience$15.22M3.92-$60.51M-$2.36-1.03

Aadi Bioscience has a net margin of -272.66% compared to Checkpoint Therapeutics' net margin of -31,427.48%. Checkpoint Therapeutics' return on equity of 0.00% beat Aadi Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Checkpoint Therapeutics-31,427.48% N/A -722.76%
Aadi Bioscience -272.66%-45.78%-39.28%

Summary

Checkpoint Therapeutics and Aadi Bioscience tied by winning 8 of the 16 factors compared between the two stocks.


Get Checkpoint Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CKPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CKPT vs. The Competition

MetricCheckpoint TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$54.59M$6.69B$4.90B$7.55B
Dividend YieldN/A2.83%5.38%3.87%
P/E RatioN/A15.64256.9218.34
Price / Sales287.31224.282,902.0477.05
Price / CashN/A21.0832.6528.75
Price / Book-1.235.124.474.46
Net Income-$62.62M$152.61M$112.29M$212.34M
7 Day Performance13.73%4.81%4.12%1.99%
1 Month Performance20.83%14.91%12.39%6.27%
1 Year Performance-55.38%7.51%13.13%7.59%

Checkpoint Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AADI
Aadi Bioscience
2.8882 of 5 stars
$1.91
+0.5%
$24.67
+1,191.4%
-79.4%$46.85M$15.22M-0.8188Short Interest ↓
Gap Up
BYSI
BeyondSpring
0.2484 of 5 stars
$1.18
-11.3%
$1.25
+5.9%
-19.8%$45.93M$1.35M0.0073Short Interest ↓
Positive News
FIXX
Homology Medicines
4.5936 of 5 stars
$0.82
+2.5%
$9.50
+1,053.1%
-37.5%$47.63M$3.21M-0.3692
BIVI
BioVie
1.9717 of 5 stars
$1.12
-8.9%
$8.00
+614.3%
-72.5%$44.65MN/A-0.9618Options Volume
News Coverage
ELDN
Eledon Pharmaceuticals
3.4325 of 5 stars
$1.84
+0.5%
$10.67
+479.7%
-34.3%$44.53MN/A-0.3317Short Interest ↓
Gap Up
IPA
ImmunoPrecise Antibodies
2.0204 of 5 stars
$1.86
-5.6%
$8.00
+330.1%
-56.0%$48.96M$15.61M-3.96102News Coverage
NXTC
NextCure
4.4136 of 5 stars
$1.57
+7.5%
$5.50
+250.3%
+19.3%$43.80MN/A-0.6799Upcoming Earnings
Positive News
Gap Up
High Trading Volume
LTRN
Lantern Pharma
2.5771 of 5 stars
$3.99
-3.6%
$11.00
+175.7%
-25.1%$43.37MN/A-2.8522Gap Up
High Trading Volume
BOLT
Bolt Biotherapeutics
2.5639 of 5 stars
$1.14
-5.0%
$7.00
+514.0%
-27.1%$43.29M$5.73M-0.6094Gap Up
MIST
Milestone Pharmaceuticals
3.1939 of 5 stars
$1.50
-2.0%
$12.75
+750.0%
-49.5%$50.22M$5M-1.0939

Related Companies and Tools

This page (NASDAQ:CKPT) was last updated on 3/4/2024 by MarketBeat.com Staff